{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:49:51Z","timestamp":1775461791465,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15607"],"award-info":[{"award-number":["23K15607"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03173, 23K24432"],"award-info":[{"award-number":["22H03173, 23K24432"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08586"],"award-info":[{"award-number":["17K08586"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04832-2","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:27:33Z","timestamp":1763998053000},"page":"6609-6622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Possible contribution of the STAT3 signaling pathway to disseminated intravascular coagulation (DIC) in mice with cecal ligation and puncture-induced sepsis"],"prefix":"10.1007","volume":"399","author":[{"given":"Samar","family":"Imbaby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Hiraide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayata","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"4832_CR1","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood.V87.10.4261.bloodjournal87104261","volume":"87","author":"A Ayala","year":"1996","unstructured":"Ayala A, Herdon CD, Lehman DL, Ayala CA, Chaudry IH (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87:4261\u20134275","journal-title":"Blood"},{"key":"4832_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252206","volume":"16","author":"SH Belok","year":"2021","unstructured":"Belok SH, Bosch NA, Kling ES, Walkey AJ (2021) Evaluation of leucopenia during sepsis as a marker of sepsis-defining organ dysfunction. PLoS ONE 16:e0252206. https:\/\/doi.org\/10.1371\/journal.pone.0252206","journal-title":"PLoS ONE"},{"key":"4832_CR3","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest 101:1644\u20131655. https:\/\/doi.org\/10.1378\/chest.101.6.1644","journal-title":"Chest"},{"issue":"Suppl 1","key":"4832_CR4","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/S0049-3848(08)70018-5","volume":"122","author":"S Butenas","year":"2008","unstructured":"Butenas S, Orfeo T, Mann KG (2008) Tissue Factor Activity and Function in Blood Coagulation 122(Suppl 1):S42\u2013S46. https:\/\/doi.org\/10.1016\/S0049-3848(08)70018-5","journal-title":"Tissue Factor Activity and Function in Blood Coagulation"},{"key":"4832_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-019-2015-1","volume":"10","author":"C Cao","year":"2019","unstructured":"Cao C, Yu M, Chai Y (2019) Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis 10:782. https:\/\/doi.org\/10.1038\/s41419-019-2015-1","journal-title":"Cell Death Dis"},{"issue":"2","key":"4832_CR6","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9608","volume":"21","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Liu B, Qian H, Yang H, Wang Y, Wu Y, Shen F (2021) <article-title update=\"added\">BAY11\u20117082 inhibits the expression of tissue factor and plasminogen activator inhibitor\u20111 in type\u2011II alveolar epithelial cells following TNF\u2011\u03b1 stimulation via the NF\u2011\u03baB pathway. Exp Ther Med 21(2):177. https:\/\/doi.org\/10.3892\/etm.2020.9608","journal-title":"Exp Ther Med"},{"key":"4832_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2741\/1796","volume":"11","author":"AJ Chu","year":"2006","unstructured":"Chu AJ (2006) Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit. Front Biosci 11:256\u2013271. https:\/\/doi.org\/10.2741\/1796","journal-title":"Front Biosci"},{"key":"4832_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.21037\/cdt.2018.10.14","volume":"8","author":"G Cimmino","year":"2018","unstructured":"Cimmino G, Cirillo P (2018) Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis. Cardiovasc Diagn Ther 8:581\u2013593. https:\/\/doi.org\/10.21037\/cdt.2018.10.14","journal-title":"Cardiovasc Diagn Ther"},{"key":"4832_CR9","doi-asserted-by":"publisher","first-page":"1210219","DOI":"10.3389\/fimmu.2023.1210219","volume":"14","author":"D Cox","year":"2023","unstructured":"Cox D (2023) Sepsis \u2013 it is all about the platelets. Front Immunol 14:1210219. https:\/\/doi.org\/10.3389\/fimmu.2023.1210219","journal-title":"Front Immunol"},{"key":"4832_CR10","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/j.1538-7836.2004.00955.x","volume":"2","author":"J-F Dhainaut","year":"2004","unstructured":"Dhainaut J-F, Yan SB, Joyce DE, Pettil\u00e4 V, Basson B, Brandt JT, Sundin DP, Levi M (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2:1924\u20131933. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00955.x","journal-title":"J Thromb Haemost"},{"key":"4832_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.mam.2008.01.001","volume":"29","author":"E Di Cera","year":"2008","unstructured":"Di Cera E (2008) Thrombin. Mol Aspects Med 29:203\u2013254. https:\/\/doi.org\/10.1016\/j.mam.2008.01.001","journal-title":"Mol Aspects Med"},{"key":"4832_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-1488-4_1","volume":"2321","author":"S Drechsler","year":"2021","unstructured":"Drechsler S, Osuchowski M (2021) Cecal ligation and puncture. Methods Mol Biol 2321:1\u20138. https:\/\/doi.org\/10.1007\/978-1-0716-1488-4_1","journal-title":"Methods Mol Biol"},{"key":"4832_CR13","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","volume":"2","author":"S Gando","year":"2016","unstructured":"Gando S, Levi M, Toh C-H (2016) Disseminated intravasvular coagulation. Nat Rev Dis Primers 2:16037. https:\/\/doi.org\/10.1038\/nrdp.2016.37","journal-title":"Nat Rev Dis Primers"},{"key":"4832_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100864","volume":"50","author":"M Giustozzi","year":"2021","unstructured":"Giustozzi M, Ehrlinder H, Bongiovanni D, Borovac JA, Guerreiro RA, Gasecka A, Papakonstantinou PE, Parker WA (2021) Coagulopathy and sepsis: pathophysiology, clinical manifestations and treatment. Blood Rev 50:100864. https:\/\/doi.org\/10.1016\/j.blre.2021.100864","journal-title":"Blood Rev"},{"key":"4832_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/245835","volume":"2012","author":"K Hanai","year":"2012","unstructured":"Hanai K, Kojima T, Ota M, Onodera J, Sawada N (2012) Effects of atelocollagen formulation containing oligonucleotide on endothelial permeability. J Drug Deliv 2012:245835. https:\/\/doi.org\/10.1155\/2012\/245835","journal-title":"J Drug Deliv"},{"key":"4832_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pharmthera.2017.02.040","volume":"177","author":"Y Hattori","year":"2017","unstructured":"Hattori Y, Hattori K, Suzuki T, Matsuda N (2017) Recent advances in the pathophysilogy and molecular basis of sepsis-associated organ dysfunction: novel therapeutic implications and challenges. Pharmacol Ther 177:55\u201366. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.040","journal-title":"Pharmacol Ther"},{"key":"4832_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ejphar.2018.06.031","volume":"833","author":"Y Hattori","year":"2018","unstructured":"Hattori Y, Hattori K, Suzuki T, Palikhe S, Matsuda N (2018) Nucleic-acid based gene therapy approaches for sepsis. Eur J Pharmacol 833:403\u2013410. https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.031","journal-title":"Eur J Pharmacol"},{"key":"4832_CR18","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1128\/IAI.00464-15","volume":"83","author":"K Hilliard","year":"2015","unstructured":"Hilliard K, Allen E, Traber KE, Kim Y, Wasserman GA, Jones MR, Mizgerd JP, Quinton LJ (2015) Activation of hepatic STAT3 maintains pulmonary defense during endotoxemia. Infect Immun 83:4015\u20134027. https:\/\/doi.org\/10.1128\/IAI.00464-15","journal-title":"Infect Immun"},{"key":"4832_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","volume":"31","author":"EJ Hillmer","year":"2016","unstructured":"Hillmer EJ, Zhang H, Li HS, Watowich SS (2016) STAT3 signaling in immunity. Cytokine Growth Factor Rev 31:1\u201315. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.05.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"4832_CR20","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","volume":"19","author":"T Hirano","year":"2000","unstructured":"Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548\u20132556. https:\/\/doi.org\/10.1038\/sj.onc.1203551","journal-title":"Oncogene"},{"key":"4832_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/jcm8030353","volume":"8","author":"P Hohlstein","year":"2019","unstructured":"Hohlstein P, Gussen H, Bartneck M, Warzecha KT, Roderburg C, Buendgens L, Trautwein C, Koch A, Tacke F (2019) Prognostic relevance of altered lymphocyte subpopulations in critical illness and sepsis. J Clin Med 8:353. https:\/\/doi.org\/10.3390\/jcm8030353","journal-title":"J Clin Med"},{"key":"4832_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1076029613492875","volume":"20","author":"D Hoppensteadt","year":"2014","unstructured":"Hoppensteadt D, Tsuruta K, Cunanan J, Hirman J, Kaul I, Osawa Y, Fareed J (2014) Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin. Clin Appl Thromb Hemost 20:129\u2013135. https:\/\/doi.org\/10.1177\/1076029613492875","journal-title":"Clin Appl Thromb Hemost"},{"key":"4832_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.581","volume":"7","author":"K Hoshino","year":"2020","unstructured":"Hoshino K, Nakashio M, Maruyama J, Irie Y, Kawano Y, Ishikura H (2020) Validating plasminogen activator inhibitor-1 as a poor prognostic factor in sepsis. Acute Med Surg 7:e581. https:\/\/doi.org\/10.1002\/ams2.581","journal-title":"Acute Med Surg"},{"key":"4832_CR24","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","volume":"27","author":"RS Hotchkiss","year":"1999","unstructured":"Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230\u20131251. https:\/\/doi.org\/10.1097\/00003246-199907000-00002","journal-title":"Crit Care Med"},{"key":"4832_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40560-017-0250-z","volume":"5","author":"T Iba","year":"2017","unstructured":"Iba T, Thachil J (2017) Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis. J Intensive Care 5:56. https:\/\/doi.org\/10.1186\/s40560-017-0250-z","journal-title":"J Intensive Care"},{"key":"4832_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017046","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Di Nishio M, Levy JH, Kitamura N, Thachil J (2017) New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open 7:e017046. https:\/\/doi.org\/10.1136\/bmjopen-2017-017046","journal-title":"BMJ Open"},{"key":"4832_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ams2.411","volume":"6","author":"T Iba","year":"2019","unstructured":"Iba T, Umemura Y, Watanabe E, Wada E, Wada T, Hayashida K, Kushimoto S, Japanese Surviving Sepsis Campaign Guideline Working Group for disseminated intravascular coagulation (2019) Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy. Acute Med Surg 6:223\u2013232. https:\/\/doi.org\/10.1002\/ams2.411","journal-title":"Acute Med Surg"},{"key":"4832_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13613-024-01380-5","volume":"14","author":"T Iba","year":"2024","unstructured":"Iba T, Helms J, Levy JH (2024) Sepsis-induced coagulopathy (SIC) in the management of sepsis. Ann Intensive Care 14:148. https:\/\/doi.org\/10.1186\/s13613-024-01380-5","journal-title":"Ann Intensive Care"},{"key":"4832_CR29","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1097\/CCM.0000000000003009","volume":"46","author":"T Imaizumi","year":"2018","unstructured":"Imaizumi T, Matsuda N, Tomita K, Palikhe S, Ohashi W, Hattori K, Hattori Y (2018) Activator protein-1 decoy oligodeoxynucleotide transfection is beneficial in reducing organ injury and mortality in septic mice. Crit Care Med 46:e435\u2013e442. https:\/\/doi.org\/10.1097\/CCM.0000000000003009","journal-title":"Crit Care Med"},{"key":"4832_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122008","volume":"330","author":"S Imbaby","year":"2023","unstructured":"Imbaby S, Hattori Y (2023) Stattic ameliorates the cecal ligation and puncture-induced cardiac injury in septic mice via IL-6-gp130-STAT3 signaling pathway. Life Sci 330:122008. https:\/\/doi.org\/10.1016\/j.lfs.2023.122008","journal-title":"Life Sci"},{"key":"4832_CR31","doi-asserted-by":"publisher","first-page":"15316","DOI":"10.1038\/s41598-020-72136-x","volume":"10","author":"S Imbaby","year":"2020","unstructured":"Imbaby S, Matsuda N, Tomita K, Hattori K, Palikhe S, Yokoo H, Hattori Y (2020) Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ in jury and mortality in mice with cecal ligation and puncture-induced sepsis. Sci Rep 10:15316. https:\/\/doi.org\/10.1038\/s41598-020-72136-x","journal-title":"Sci Rep"},{"key":"4832_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2141.2012.09074.x","volume":"157","author":"T Iwaki","year":"2012","unstructured":"Iwaki T, Urano T, Umemura K (2012) PAI-1, progress in understanding the clinical problem and its aetiology. Br J Haematol 157:294\u2013298. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09074.x","journal-title":"Br J Haematol"},{"key":"4832_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jnc.14329","volume":"145","author":"M Kawakami","year":"2018","unstructured":"Kawakami M, Hattori M, Ohashi W, Fujimori T, Hattori K, Takebe M, Tomita K, Yokoo H, Matsuda N, Yamazaki M, Hattori Y (2018) Role of G protein-coupled receptor kinase 2 in oxidative and nitrosative stress-related neurohistopathological changes in a mouse model of sepsis-associated encephalopathy. J Neurochem 145:474\u2013488. https:\/\/doi.org\/10.1111\/jnc.14329","journal-title":"J Neurochem"},{"key":"4832_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jcrc.2018.03.011","volume":"45","author":"D Kudo","year":"2018","unstructured":"Kudo D, Kushimoto S, Miyagawa N, Sato T, Hasegawa M, Ito F, Yamanouchi S, Honda H, Andoh K, Furukawa H, Yamada Y, Tsujimoto Y, Okuyama M (2018) The impact of organ dysfunctions on mortality in patients with severe sepsis: a multicenter prospective observation study. J Crit Care 45:178\u2013183. https:\/\/doi.org\/10.1016\/j.jcrc.2018.03.011","journal-title":"J Crit Care"},{"key":"4832_CR35","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1172\/JCI15650","volume":"109","author":"DE Levy","year":"2002","unstructured":"Levy DE, Lee C (2002) What does Stat3 do? J Clin Invest 109:1143\u20131148. https:\/\/doi.org\/10.1172\/JCI15650","journal-title":"J Clin Invest"},{"key":"4832_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cll.2014.06.005","volume":"34","author":"JH Levy","year":"2014","unstructured":"Levy JH, Szlam F, Wolberg AS, Winkler A (2014) Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clin Lab Med 34:453\u2013477. https:\/\/doi.org\/10.1016\/j.cll.2014.06.005","journal-title":"Clin Lab Med"},{"key":"4832_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/01902148.2018.1505975","volume":"44","author":"B Liu","year":"2018","unstructured":"Liu B, Wu Y, Wang Y, Cheng Y, Yao L, Liu Y, Qian H, Yang H, Shen F (2018) NF-\u03baB p65 knock-down inhibits TF, PAI-1 and promotes activated protein C production in lipopolysaccharide-stimulated alveolar epithelial cell type II. Exp Lung Res 44:241\u2013251. https:\/\/doi.org\/10.1080\/01902148.2018.1505975","journal-title":"Exp Lung Res"},{"key":"4832_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.thromres.2014.04.013","volume":"134","author":"L Lorente","year":"2014","unstructured":"Lorente L, Mart\u00edn MM, Borreguero-Le\u00f3n JM, Sol\u00e9-Viol\u00e1n J, Ferreres J, Lobarta L, D\u00edaz C, Jim\u00e9nez A, P\u00e1ramo JA (2014) Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients. Thromb Res 134:182\u2013186. https:\/\/doi.org\/10.1016\/j.thromres.2014.04.013","journal-title":"Thromb Res"},{"key":"4832_CR39","doi-asserted-by":"publisher","first-page":"943","DOI":"10.21037\/jtd.2017.03.125","volume":"9","author":"PE Marik","year":"2017","unstructured":"Marik PE, Taeb AM (2017) SIRS, qSOFA and new sepsis definition. J Thorac Dis 9:943\u2013945. https:\/\/doi.org\/10.21037\/jtd.2017.03.125","journal-title":"J Thorac Dis"},{"key":"4832_CR40","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1097\/CCM.0b013e3181ab844d","volume":"37","author":"N Matsuda","year":"2009","unstructured":"Matsuda N, Yamamoto S, Yokoo H, Tobe K, Hattori Y (2009) Nuclear factor-\u03baB decoy oligodeoxynucleotides ameliorate impaired glucose tolerance and insulin resistance in mice with cecal ligation and puncture-induced sepsis. Crit Care Med 37:2791\u20132799. https:\/\/doi.org\/10.1097\/CCM.0b013e3181ab844d","journal-title":"Crit Care Med"},{"key":"4832_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.taap.2017.09.003","volume":"334","author":"H Misawa","year":"2017","unstructured":"Misawa H, Ohashi W, Tomita K, Hattori K, Shimada Y, Hattori Y (2017) Prostacyclin mimetics afford protection against lipopolysaccharide\/d-galactosamine-induced acute liver injury in mice. Toxicol Appl Pharmacol 334:55\u201365. https:\/\/doi.org\/10.1016\/j.taap.2017.09.003","journal-title":"Toxicol Appl Pharmacol"},{"key":"4832_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.thromres.2023.05.018","volume":"228","author":"KM Musgrave","year":"2023","unstructured":"Musgrave KM, Scott J, Sendama W, Gardner AI, Dewar F, Lake CJ, Spronk HMH, van Oerle R, Visser M, Cate HT, Kesteven P, Fuller A, McDonald D, Knill C, Hulme G, Filby A, Wright SE, Roy AI, Ruchaud-Sparagano M-H, Simpson AJ, Rostron AJ (2023) Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis. Thromb Res 228:10\u201320. https:\/\/doi.org\/10.1016\/j.thromres.2023.05.018","journal-title":"Thromb Res"},{"key":"4832_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.micpath.2017.08.047","volume":"111","author":"RS Pereira","year":"2017","unstructured":"Pereira RS, Bertoncheli CM, Adefegha SA, Castilhos LG, Silveira KL, Rezer JFP, Doleski PH, Abdalla FH, Santos KF, Leal CAM, Santos RCV, Casali EA, Moritz CEJ, Stainki DR, Leal DBR (2017) Sepsis induced by cecal ligation and perforation (CLP) alters nucleotidase activities in platelets of rats. Microb Pathog 111:345\u2013351. https:\/\/doi.org\/10.1016\/j.micpath.2017.08.047","journal-title":"Microb Pathog"},{"key":"4832_CR44","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1182\/blood.202007208","volume":"139","author":"NI Popescu","year":"2022","unstructured":"Popescu NI, Lupu C, Lupu F (2022) Disseminated intravascular coagulation and its immune mechanisms. Blood 139:1973\u20131986. https:\/\/doi.org\/10.1182\/blood.202007208","journal-title":"Blood"},{"key":"4832_CR45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.016645","volume":"296","author":"DK Poria","year":"2022","unstructured":"Poria DK, Sheshadri N, Balamurugan K, Sharan S, Sterneck E (2022) The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression. J Biol Chem 296:100220. https:\/\/doi.org\/10.1074\/jbc.RA120.016645","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"4832_CR46","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.21037\/jtd.2019.12.51","volume":"12","author":"C Rhee","year":"2020","unstructured":"Rhee C, Klompas M (2020) Sepsis trends: increasing incidence and decreasing mortality, or changing denominator? J Thorac Dis 12(Suppl):S89\u2013S100. https:\/\/doi.org\/10.21037\/jtd.2019.12.51","journal-title":"J Thorac Dis"},{"key":"4832_CR47","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.3390\/jcm11216480","volume":"11","author":"I Rinaldi","year":"2022","unstructured":"Rinaldi I, Sudaryo MK, Prihartono NA (2022) Disseminated intravascular coagulation in sepsis and associated factors. J Clin Med 11:6480. https:\/\/doi.org\/10.3390\/jcm11216480","journal-title":"J Clin Med"},{"key":"4832_CR48","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1177\/0885066618794136","volume":"35","author":"M Rubens","year":"2020","unstructured":"Rubens M, Saxena A, Ramamoorthy V, Das S, Khera R, Hong J, Armaignac D, Veledar E, Nasir K, Gidel L (2020) Increasing sepsis rates in the United States: results from national inpatient sample, 2005 to 2014. J Intensive Care Med 35:858\u2013868. https:\/\/doi.org\/10.1177\/0885066618794136","journal-title":"J Intensive Care Med"},{"key":"4832_CR49","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart K, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano AD, Lopez AD, Angus DC, Murray CJL, Naghavi M (2020) Lancet 395:200\u2013211. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7","journal-title":"Lancet"},{"key":"4832_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jcrc.2018.11.009","volume":"50","author":"S Saito","year":"2019","unstructured":"Saito S, Uchino S, Hayakawa M, Yamakawa K, Kudo D, Iizuka Y, Sanui M, Takimoto K, Mayumi T, Sasabuchi Y, Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group (2019) Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. J Crit Care 50:23\u201330. https:\/\/doi.org\/10.1016\/j.jcrc.2018.11.009","journal-title":"J Crit Care"},{"key":"4832_CR51","doi-asserted-by":"publisher","first-page":"H1224","DOI":"10.1152\/ajpheart.00828.2016","volume":"312","author":"M Sakai","year":"2017","unstructured":"Sakai M, Suzuki T, Tomita K, Yamashita S, Palikhe S, Hattori K, Yoshimura N, Matsuda N, Hattori Y (2017) Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation. Am J Physiol Heart Circ Physiol 312:H1224\u2013H1237. https:\/\/doi.org\/10.1152\/ajpheart.00828.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4832_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70152","volume":"6","author":"MA Samad","year":"2020","unstructured":"Samad MA, Ahmad I, Hasan A, Alhashmi MH, Ayub A, Al-Abbasi KA, Tabrez S (2020) STAT3 signaling pathway in health and disease. MedComm 6:e70152. https:\/\/doi.org\/10.1002\/mco2.70152","journal-title":"MedComm"},{"key":"4832_CR53","doi-asserted-by":"publisher","first-page":"107602962211378","DOI":"10.1177\/10760296221137893","volume":"28","author":"T Schupp","year":"2022","unstructured":"Schupp T, Weidner K, Rusnak J, Jawhar S, Forner J, Dulatahu F, Br\u00fcck LM, Hoffmann U, Bertsch T, M\u00fcller J, Wei\u03b2 C, Akin I, Behnes M (2022) Diagnostic and prognostic significance of the prothrombin time\/international normalized ratio in sepsis and septic shock. Clin Appl Thromb Hemost 28:10760296221137892. https:\/\/doi.org\/10.1177\/10760296221137893","journal-title":"Clin Appl Thromb Hemost"},{"key":"4832_CR54","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust J, Sperl B, Hollis A, Mayer TU, Berg T (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 13:1235\u20131242. https:\/\/doi.org\/10.1016\/j.chembiol.2006.09.018","journal-title":"Chem Biol"},{"key":"4832_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","volume":"129","author":"N Semeraro","year":"2012","unstructured":"Semeraro N, Ammollo CT, Semeraro F, Colucci M (2012) Sepsis, thrombosis and oxygen dysfunction. Thromb Res 129:290\u2013295. https:\/\/doi.org\/10.1016\/j.thromres.2011.10.013","journal-title":"Thromb Res"},{"key":"4832_CR56","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1055\/s-0035-1556730","volume":"41","author":"N Semeraro","year":"2015","unstructured":"Semeraro N, Ammollo CT, Semeraro F, Colucci M (2015) Coagulopathy of acute sepsis. Semin Thromb Hemost 41:650\u2013658. https:\/\/doi.org\/10.1055\/s-0035-1556730","journal-title":"Semin Thromb Hemost"},{"key":"4832_CR57","doi-asserted-by":"publisher","first-page":"L1282","DOI":"10.1152\/ajplung.00349.2003","volume":"286","author":"M Severgnini","year":"2004","unstructured":"Severgnini M, Takahashi S, Rozo LM, Homer RJ, Kuhn C, Jhung JW, Perides G, Steer M, Hassoun PM, Fanburg B, Cochran BH, Simon AR (2004) Activation of the STAT pathway in acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L1282\u2013L1292. https:\/\/doi.org\/10.1152\/ajplung.00349.2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4832_CR58","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3390\/ijms22052721","volume":"22","author":"M Sillen","year":"2021","unstructured":"Sillen M, Declerck PJ (2021) A narrative review on plasminogen activator inhibitor-1 and its (patho)physiological role: to target or not to target. Int J Mol Sci 22:2721. https:\/\/doi.org\/10.3390\/ijms22052721","journal-title":"Int J Mol Sci"},{"key":"4832_CR59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"4832_CR60","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/SHK.0b013e318173ef9c","volume":"30","author":"R Taneja","year":"2008","unstructured":"Taneja R, Sharma AP, Hallett MB, Findlay GP, Morris MR (2008) Immature circulating neutrophils in sepsis have impaired phagocytosis and calcium signaling. Shock 30:618\u2013622. https:\/\/doi.org\/10.1097\/SHK.0b013e318173ef9c","journal-title":"Shock"},{"key":"4832_CR61","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3389\/fimmu.2018.01218","volume":"9","author":"TL Tipoe","year":"2018","unstructured":"Tipoe TL, Wu WKK, Chung L, Gong M, Dong M, Liu T, Roever L, Ho J, Wong MCS, Chan MTV, Tse G, Wu JCY, Wong SH (2018) Plasminogen activator inhibitor 1 for predicting sepsis severity and mortality: a systematic review and meta-analysis. Front Immunol 9:1218. https:\/\/doi.org\/10.3389\/fimmu.2018.01218","journal-title":"Front Immunol"},{"key":"4832_CR62","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s00210-020-01947-6","volume":"393","author":"K Tomita","year":"2020","unstructured":"Tomita K, Saito Y, Suzuki T, Imbaby S, Hattori K, Matsuda N, Hattori Y (2020) Vascular endothelial growth factor contributes to lung vascular hyperpermeability in sepsis-associated acute lung injury. Naunyn-Schmiedebergs Arch Pharmacol 393:2365\u20132374. https:\/\/doi.org\/10.1007\/s00210-020-01947-6","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"4832_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.884","volume":"10","author":"Y Umemura","year":"2023","unstructured":"Umemura Y, Nishida T, Yamakawa K, Ogura H, Oda J, Fujimi S (2023) Anticoagulant therapies against sepsis-induced disseminated intravascular coagulation. Acute Med Surg 10:e884. https:\/\/doi.org\/10.1002\/ams2.884","journal-title":"Acute Med Surg"},{"key":"4832_CR64","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3390\/cells12172120","volume":"12","author":"A Unar","year":"2023","unstructured":"Unar A, Bertolino L, Patauner F, Gallo R, Durante-Mangoni E (2023) Pathophysiology of disseminated intravascular coagulation in sepsis: A clinically focused overview. Cells 12:2120. https:\/\/doi.org\/10.3390\/cells12172120","journal-title":"Cells"},{"key":"4832_CR65","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.thromres.2012.06.023","volume":"130","author":"B Van De Craen","year":"2012","unstructured":"Van De Craen B, Declerck PJ, Gils A (2012) The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thromb Res 130:576\u2013585. https:\/\/doi.org\/10.1016\/j.thromres.2012.06.023","journal-title":"Thromb Res"},{"key":"4832_CR66","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/jth.15246","volume":"19","author":"LA van Vught","year":"2021","unstructured":"van Vught LA, Uhel F, Ding C, van\u2019t Veer C, Scicluna BP, Peters-Sengers H, Klouwenberg PMCK, N\u00fcrnberg P, Cremer O, Schultz MJ, van der Poll T, MARS consortium (2021) Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis. J Thromb Haemost 19:1049\u20131063. https:\/\/doi.org\/10.1111\/jth.15246","journal-title":"J Thromb Haemost"},{"key":"4832_CR67","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00134-008-1337-8","volume":"35","author":"F Venet","year":"2009","unstructured":"Venet F, Chung C-S, Kherouf H, Geeraert A, Malcus C, Poitevin F, Boh\u00e9 J, Lepape A, Ayala A, Monneret G (2009) Increased circulating regulatory T cells (CD4+CD25+CD127-) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35:678\u2013686. https:\/\/doi.org\/10.1007\/s00134-008-1337-8","journal-title":"Intensive Care Med"},{"key":"4832_CR68","doi-asserted-by":"publisher","first-page":"1257988","DOI":"10.3389\/fimmu.2023.1257988","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Fang C, Yao M, Wu D, Chen M, Guo T, Mo J (2023) Research progress of NF-\u03baB signaling pathway and thrombosis. Front Immunol 14:1257988. https:\/\/doi.org\/10.3389\/fimmu.2023.1257988","journal-title":"Front Immunol"},{"key":"4832_CR69","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1681\/ASN.2009060663","volume":"21","author":"JE Wiggins","year":"2010","unstructured":"Wiggins JE, Patel SR, Shedden KA, Goyal M, Wharram BL, Martini S, Kretzler M, Wiggins RC (2010) NF\u03baB promotes inflammation, coagulation, and fibrosis on the aging glomerulus. J Am Soc Nephrol 21:587\u2013597. https:\/\/doi.org\/10.1681\/ASN.2009060663","journal-title":"J Am Soc Nephrol"},{"key":"4832_CR70","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jphs.2023.03.005","volume":"152","author":"T Yamamoto","year":"2023","unstructured":"Yamamoto T, Machida T, Tanno C, Hasebe S, Tamura M, Kobayashi N, Hiraide S, Hamaue N, Iizuka K (2023) Low-dose nafamostat mesilate ameliorates tissue injury and inhibits 5-hydroxytryptamine synthesis in the rat intestine after methotrexate administration. J Pharmacol Sci 152:90\u2013102. https:\/\/doi.org\/10.1016\/j.jphs.2023.03.005","journal-title":"J Pharmacol Sci"},{"key":"4832_CR71","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00210-018-1527-z","volume":"391","author":"S Yamashita","year":"2018","unstructured":"Yamashita S, Suzuki T, Iguchi K, Sakamoto T, Tomita K, Yokoo H, Sakai M, Misawa H, Hattori K, Nagata T, Watanabe Y, Matsuda N, Yoshimura N, Hattori Y (2018) Cardioprotective and functional effects of levosimendan and milrinone in mice with cecal ligation and puncture-induced sepsis. Naunyn-Schmiedebergs Arch Pharmacol 391:1021\u20131032. https:\/\/doi.org\/10.1007\/s00210-018-1527-z","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"4832_CR72","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9:798\u2013809. https:\/\/doi.org\/10.1038\/nrc2734","journal-title":"Nat Rev Cancer"},{"key":"4832_CR74","doi-asserted-by":"publisher","first-page":"L868","DOI":"10.1152\/ajplung.00281.2016","volume":"311","author":"J Zhao","year":"2016","unstructured":"Zhao J, Yu H, Liu Y, Gibson SA, Yan Z, Xu X, Gaggar A, Li P-K, Li C, Wei S, Benveniste EN, Qin H (2016) Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 311:L868\u2013L880. https:\/\/doi.org\/10.1152\/ajplung.00281.2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04832-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:52:55Z","timestamp":1775458375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04832-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4832"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04832-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were approved by the Animal Care and Use Committee of the University of Toyama and the Animal Research Committee of Health Sciences University of Hokkaido, which are based on the National Institute of Health Guide for the Care and Use of Laboratory Animals and the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}